Prolipid Composition for Stratum Corneum Lipid Restoration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current topical compositions struggle to effectively penetrate and restore the skin's natural lipid balance in the stratum corneum, leading to short-lived benefits and increased sensitivity to environmental contaminants, as they fail to efficiently deliver fatty acids and lipids deep into the skin.

Innovation Solution

A prolipid composition comprising a C6 to C18 fatty acid, ester, or acylglycerol, combined with an activator of a peroxisome proliferator-activated receptor (PPAR) and an elongation source, which penetrates the stratum corneum to enhance fatty acid elongation and lipid production, creating a long-lasting skin resilience barrier.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional lipid formulations are used to fortify the skin's fatty acid and lipid matrix, then the skin barrier function is improved, but the penetration depth into the stratum corneum is insufficient

Engineering Contradiction:
Improveskin barrier functionVSAvoidpenetration depth
Core Design Contradiction:
ReliabilityVSLength of stationary object

Solution Approach 1:

The patent changes the molecular parameters of the lipid formulation by using specific fatty acid profiles (including long-chain fatty acids like C20-C36) and controlling the ratio of different lipid components. This parameter optimization enables deeper penetration into the stratum corneum while maintaining barrier function, resolving the contradiction between penetration depth and barrier improvement.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs an intermediary delivery system that facilitates the transport of lipid molecules through the stratum corneum. This intermediary mechanism enables conventional lipid formulations to achieve deep penetration without compromising their barrier-function-enhancing properties, thus resolving the contradiction between penetration depth and reliability of barrier function.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If lipid formulations are applied to the skin surface, then the skin is protected from environmental contaminants, but the benefits are short-lived due to lack of deep penetration

Engineering Contradiction:
Improveprotection from contaminantsVSAvoidduration of benefit
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of moving object

Solution Approach 1:

The patent incorporates preliminary action by using lipid formulations that are pre-configured with specific molecular structures and compositions that enable deep penetration upon application. This preliminary design ensures that the lipids are delivered to their target location in the stratum corneum, establishing long-lasting protection against environmental contaminants rather than providing only temporary surface-level benefits.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent achieves continuity of useful action by formulating lipids that continue to function deeply within the stratum corneum over extended periods. The specific lipid composition and molecular structure enable sustained activity and prolonged protection from environmental contaminants, transforming short-lived surface protection into long-lasting deep-tissue protection.

Inventive Principle:
Principle #20Continuity of useful action

3Object-affected harmful factors

If the skin's lipid matrix is depleted, then the skin becomes more sensitive to environmental factors, but conventional approaches fail to restore the lipid balance rapidly

Engineering Contradiction:
Improvesensitivity to environmental factorsVSAvoidrate of lipid restoration
Core Design Contradiction:
Object-affected harmful factorsVSSpeed

Solution Approach 1:

The patent optimizes the parameters of the lipid formulation, including the specific fatty acid composition (with emphasis on long-chain fatty acids C20-C36) and the molecular weight distribution. These parameter changes enable rapid penetration and restoration of the skin's lipid matrix, quickly reducing sensitivity to environmental factors without the delays associated with conventional formulations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces conventional mechanical application methods with a biochemically-active lipid formulation that actively restores the skin's lipid matrix through biological mechanisms. This substitution enables rapid restoration of lipid balance and reduction of environmental sensitivity, overcoming the slow restoration rates of conventional approaches.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves a long-lasting restoration of the skin's natural lipid balance, improving skin health and appearance by enhancing fatty acid and lipid production, providing long-lasting moisturization and protection from environmental contaminants.

Implementation Method 1

an activator of a peroxisome proliferator-activated receptor

Methodology Applied
Scientific EffectPeroxisome proliferator-activated receptor activation:

Data Source

PatentUS20240050342A1Prolipid composition for personalized benefits and method for using the same
Publication Date: 2024.02.15 CONOPCO INC

AI summary

The present invention is directed to a prolipid composition that penetrates the stratum corneum. More particularly, the invention is directed to a prolipid composition that provides personalized benefits by rapidly restoring the skins natural lipid balance. Such a composition results in elongated fatty acid and/or lipid production deep in the stratum corneum and near the surface of the stratum lucidum. The composition at least comprises a fatty acid, fatty ester and/or an acylglycerol and an activator of a peroxisome proliferator-activated receptor.